NovoCure Limited
NASDAQ:NVCR · NASDAQ Global Select
-$3.51 today
Vol 4.63M · Avg 1.52M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-14.03%
Period High
$18.46
Period Low
$10.03
Latest
$14.28
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Establishment Labs Holdings Inc.
NASDAQ:ESTA
$2.51B
Neogen Corporation
NASDAQ:NEOG
$1.98B
Pulse Biosciences, Inc.
NASDAQ:PLSE
$1.83B
STAAR Surgical Company
NASDAQ:STAA
$1.44B
Teladoc Health, Inc.
NYSE:TDOC
$1.41B
BioLife Solutions, Inc.
NASDAQ:BLFS
$1.26B
Kestra Medical Technologies, Ltd.
NASDAQ:KMTS
$1.11B
Azenta, Inc.
NASDAQ:AZTA
$1.05B
Evotec SE
NASDAQ:EVO
$928.82M
Upstream Bio, Inc.
NASDAQ:UPB
$339.04M
What is the latest NVCR filing?
The latest filing shown is 8-K dated Jun 18, 2026.
How many recent filings does NVCR have?
Intrinsic Alpha currently shows 20 recent filings for NVCR.
Explore More
Continue the stock analysis
Jump to another research area for this company.